Publications by authors named "Daiki Kayano"

Claim this Profile
[
[The 46th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (The 49th Survey in 2023)].

Kaku Igaku· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 13th World Federation of Nuclear Medicine and Biology congress (WFNMB 2022): summarize the past half century and discuss the next half century of WFNMB.
Hirofumi Fujii, Hiroshi Toyama, Daiki Kayano, Kazunari Ishii, Seigo Kinuya

Ann Nucl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry.
Zhuoqing Chen, Hiroshi Wakabayashi, Rie Kuroda, Hiroshi Mori, Tomo Hiromasa, Daiki Kayano

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
Xue Zhang, Hiroshi Wakabayashi, Tomo Hiromasa, Daiki Kayano, Seigo Kinuya

Semin Nucl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.
Norihito Akatani, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Aki Takata

Endocr J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study.
Akihiko Takeuchi, Makoto Endo, Akira Kawai, Yoshihiro Nishida, Ryu Terauchi, Daiki Kayano

Front Oncol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paraganglioma.
Xue Zhang, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Seigo Kinuya

Nuklearmedizin· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Anri Inaki, Tohru Shiga, Yoshito Tsushima, Megumi Jinguji, Hiroshi Wakabayashi, Daiki Kayano

Ann Nucl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors for refractory pheochromocytoma and paraganglioma after I-metaiodobenzylguanidine therapy.
Tomo Hiromasa, Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Satoru Watanabe

Ann Nucl Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during I-meta-iodo-benzyl-guanidine therapy.
Yuka Taniguchi, Hiroshi Wakabayashi, Hiroto Yoneyama, Zhuoqing Chen, Kei Morino, Daiki Kayano

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Radiation Protection Against Exposure from Patients Receiving I-MIBG and Released from Radiation Treatment Room].
Anri Inaki, Hiroshi Wakabayashi, Daiki Kayano, Seigo Kinuya

Kaku Igaku· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the detecting capability between I-mIBG and post-therapeutic I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.
Zhong-Ling Qiu, Shintaro Saito, Daiki Kayano, Hiroshi Wakabayashi, Seigo Kinuya

Ann Nucl Med· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda

Ann Nucl Med· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Use of Post-therapy I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma.
Hiroshi Wakabayashi, Daiki Kayano, Anri Inaki, Raita Araki, Rie Kuroda

Diagnostics (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis].
Hiroshi Mori, Anri Inaki, Daiki Kayano, Hiroshi Wakabayashi, Makoto Hosono

Kaku Igaku· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan.
Daiki Kayano, Hiroshi Wakabayashi, Kenichi Nakajima, Rie Kuroda, Satoru Watanabe

Ann Nucl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation exposure in nurses during care of I-MIBG therapy for pediatric patients with high-risk neuroblastoma.
Yuka Taniguchi, Hiroshi Wakabayashi, Anri Inaki, Daiki Kayano, Masako Yamada

Ann Nucl Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017.
Yoshihiro Nishiyama, Seigo Kinuya, Takashi Kato, Daiki Kayano, Shuhei Sato

Ann Nucl Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma.
Hiroshi Wakabayashi, Tahahiro Konishi, Hiroto Yoneyama, Anri Inaki, Tomo Hiromasa, Daiki Kayano

Asia Ocean J Nucl Med Biol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Consensus on I-131 MIBG Therapy.
Daiki Kayano, Seigo Kinuya

Nucl Med Mol Imaging· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete remission of metastatic pheochromocytoma in I-metaiodobenzylguanidine scintigraphy after a single session of I-metaiodobenzylguanidine therapy: a case report.
Teruaki Sugino, Ryosuke Ando, Rei Unno, Keitaro Iida, Taku Naiki, Daiki Kayano

BMC Res Notes· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extremity Radioactive Iodine Uptake on Post-therapeutic Whole Body Scan in Patients with Differentiated Thyroid Cancer.
Hiroshi Wakabayashi, Junichi Taki, Anri Inaki, Ayane Toratani, Daiki Kayano

Asia Ocean J Nucl Med Biol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.
Daiki Kayano, Seigo Kinuya

ScientificWorldJournal· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Keiichiro Yoshinaga, Noboru Oriuchi, Hiroshi Wakabayashi, Yuuki Tomiyama, Megumi Jinguji, Daiki Kayano

Endocr J· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of attenuation and scatter corrections in sentinel lymph node scintigraphy using SPECT/CT systems.
Hiroto Yoneyama, Hiroyuki Tsushima, Masahisa Onoguchi, Takahiro Konishi, Kenichi Nakajima, Daiki Kayano

Ann Nucl Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis